Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Cost-effectiveness of high-dose MR contrast studies in the evaluation of brain metastases.

Cost-effectiveness of high-dose MR contrast studies in the evaluation of brain metastases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Cost-effectiveness of high-dose MR contrast studies in the evaluation of brain metastases. Abstract Text:

    n a mayrN A Mayr,w t yuhW T Yuh,m g muhonenM G Muhonen,d j fisherD J Fisher,h d nguyenH D Nguyen,j c ehrhardtJ C Ehrhardt,b c wenB C Wen,j f doornbosJ F Doornbos,d h husseyD H Hussey,

    PURPOSE: To investigate the cost-effectiveness of high-dose MR contrast studies in the management of brain metastases. METHODS: During the phase III clinical trial of high-dose contrast studies (0.3 mmol/kg), 11 of 27 patients were judged by the reviewers to have potential treatment changes based on the additional information provided by the high-dose studies. We retrospectively evaluated how many of these 27 patients had actual treatment changes because of the results of the high-dose study. Using the fee schedule at our institution, the cost-effectiveness was analyzed based on the cost savings from treatment changes and the additional expense of implementing the high-dose studies. RESULTS: A total of 3 craniotomies ($22,800 each) and 2 aggressive courses of radiation therapy ($1122 each) were avoided in 4 patients because of the additional lesions detected by the high-dose studies. This resulted in a treatment cost savings of $70,644. The extra expense for implementing the high-dose study is $9126 for a single injection in all 27 patients, $9295 for 2 separate injections completed in 1 visit in the 11 patients, and $11,154 for 2 separate injections completed in 2 separate visits. The cost savings in management (diagnosis and treatment) therefore ranged from $59,490 to $61,518 for all patients and from $2203 to $2278 per patient. CONCLUSION: Based on our limited data, the high-dose study seems to impact positively on the cost-effectiveness in the management of brain metastases. However, because our study had limitations, our results need to be confirmed with a larger patient population and a more standardized treatment approach and fee schedule.

    Cost-effectiveness of high-dose MR contrast studies in the evaluation of brain metastases. Publishing Authors By Initials

    na mayrNA Mayr,wt yuhWT Yuh,mg muhonenMG Muhonen,dj fisherDJ Fisher,hd nguyenHD Nguyen,jc ehrhardtJC Ehrhardt,bc wenBC Wen,jf doornbosJF Doornbos,dh husseyDH Hussey,

    For similar health care economics and organizations: technology assessment, biomedical: technology, high-cost research abstracts see: health care economics and organizations: technology assessment, biomedical: technology, high-cost research

    PUBMED ID PMID:

    MEDLINE DATE:

    Cost-effectiveness of high-dose MR contrast studies in the evaluation of brain metastases. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: AJNR. American journal of neuroradiology

    VOLUME: 15

    Page Numbers: 1053-61

    Journal Abbreviation:

    ISSN: 0195-6108

    DAY: 14

    MONTH: Jun

    YEAR: 1994

    Cost-effectiveness of high-dose MR contrast studies in the evaluation of brain metastases. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8003708

    Cost-effectiveness of high-dose MR contrast studies in the evaluation of brain metastases. Keywords Mesh Terms:

    KEYWORDS: Technology, High-Cost

    MESH TERMS: economics

    Chemical & Substance for Abstract: Cost-effectiveness of high-dose MR contrast studies in the evaluation of brain metastases. Information

    Substance Name: Gadolinium

    Registry Number: 7440-54-2

    Grant and Affiliation Information for Cost-effectiveness of high-dose MR contrast studies in the evaluation of brain metastases.

    AFFILIATION: Department of Radiology, University of Iowa College of Medicine, Iowa City.

    Country: UNITED STATES

    UNITED STATES Research PublicationUNITED STATES Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: AJNR Am J Neuroradiol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Cost-effectiveness of high-dose MR contrast studies in the evaluation of brain metastases Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News